Skip to main content
2023 ACVIM Forum Main banner
Final Program


2023 Event Program
Icon Legend
This session is not on your agenda.
This session is on your agenda. Click again to remove it.
Presentation Icons
ACVIM Resident Research Award Eligible
ACVIM Resident Research Award Eligible
Additional Fees May Be Required
Additional Fees May Be Required
By Invite Only
By Invite Only
Capturing for On Demand
Capturing for On Demand
Cardiology Research Abstract Award Eligible
Cardiology Research Abstract Award Eligible
ERC Approved Lecture for ACVIM Residency
ERC Approved Lecture for ACVIM Residency
ePoster
ePoster
Livestream
Livestream
One Health
One Health
Pre-Registration Required
Pre-Registration Required
RACE-Approved
RACE-Approved
Research Abstract
Research Abstract
Specialty Symposium
Specialty Symposium
State-of-the-Art (SOTA) Presentation
State-of-the-Art (SOTA) Presentation
Veterinary Technician
Veterinary Technician
Back
Evaluation ViewAttendees 25

Multispecialty

Technician

Industry Session Breakfast: Rethinking Diabetes Mellitus Treatment in Cats

Thursday, June 15, 2023
6:30 AM – 7:50 AM ET
Location: Marriott Liberty C
CE: 1.5

Sponsored by 
Pre-Registration Required
This lecture will discuss a new medication to treat diabetes mellitus in cats, bexagliflozin. An introduction to the sodium-glucose cotransporter 2 inhibitor class of drugs including mechanism of action will be discussed. Detailed outlines of appropriate patient selection and monitoring considerations will be covered.

Learning Objectives:

  • Understand how bexagliflozin differs from insulin therapy for management of diabetes mellitus in cats
  • Identify patients that are good candidates for bexagliflozin, and understand key criteria needed to make such a determination
  • Thoroughly understand the testing needed to properly monitor patients taking bexagliflozin, and when to discontinue use of the drug